Advances in Personalized Therapeutics for IBD Management

The lecture explores current challenges and advancements in inflammatory bowel disease (IBD) treatment, emphasizing the importance of early intervention. Groundbreaking therapies, including TL1A antagonists and RNA-based treatments, target both inflammation and fibrosis. Discussing future directions, we will investigate the integration of personalized medicine and combination therapies to improve patient outcomes and reshape IBD management.